This special section of the Journal of Neural Engineering contains five invited papers presented as part of the 3rd International Conference: 'Medical Bionics: Engineering Solutions for Neural Disorders' held in the beautiful seaside resort of Phillip Island, Victoria, Australia from 17-20 November 2013. This meeting was designed to bring experts from a variety of scientific, engineering and clinical disciplines together in a unique environment to discuss current progress in the field of medical bionics and to develop the knowledge, concepts and techniques required to build the next generation of devices. The field is rapidly expanding, with new engineering solutions being developed at an astonishing rate. The successful application of these emerging technologies requires a multidisciplinary research environment in order to deliver clinical solutions that are both safe and effective; this was a major theme of the meeting.
Current clinical success stories include spinal cord stimulators for the management of chronic neurological pain, cochlear implants that allow the profoundly deaf to hear and deep brain stimulation to negate movement disorders in Parkinson's disease and essential tremor. Other research programs currently undergoing clinical trials include devices that allow spinal cord injured patients to grasp objects, brain-machine interfaces that allow patients with severe spinal cord injuries to control an artificial limb, devices that detect and suppress epileptic seizures using brief trains of electrical stimulation and vestibular prostheses designed to minimize the debilitating effects of severe balance disorders. If clinically effective each of these devices will provide a significant improvement in lifestyle and independence for hundreds of thousands of patients suffering from a variety of neurological disorders.
The future of medical bionics is very exciting but also presents major challenges. Many of these challenges are technical while others are related to the commercialisation of the technology. Without commercialisation the technology will fail to get to the clinic. The skill base in bionics has just got wider; we need to add entrepreneurs and individuals with business experience into the mix! A key component to developing successful medical bionic solutions is a good understanding of the technological developments in the many enabling technologies that contribute to this field. Meetings such as this one are designed to provide that cross-discipline background. Conference themes included: an overview of medical bionics design, development and commercialisation; fundamentals of the electrode-tissue interface from both a biological and a materials science perspective; cochlear implants, retinal prostheses and CNS devices and finally a session on emerging bionic technologies. The meeting concluded with a historical perspective of neural prosthesis development at Case Western Reserve University. The five articles arising from this meeting cover a number of these research themes.
This Neural prostheses often stimulate neural tissue that has undergone pathological changes as a result of an underlying disease process, therefore technologies designed to either regenerate neurons and/or minimise ongoing neural degeneration are likely to improve the electrode-neural interface and improve device efficacy. Gillespie et al [1] review the cell and gene-based strategies available for the delivery of therapeutic drugs into the cochlea designed to promote preservation of hearing. The review addresses the issue of clinically relevant delivery technologies. Paviolo et al [2] review recent in vitro and in vivo results using gold nanorods that are absorbed into excitable cells to enhance the process of infrared neural stimulation. George et al [3] present experimental data demonstrating significantly improved spatial selectivity of focussed multipolar and tripolar cochlear stimulation compared with monopolar stimulation which is the current gold standard for cochlear implants. Finally, Tahayori et al present two companion papers that explore modelling of excitable tissue to calculate the membrane potential in response to extracellular electrical stimulation. The first paper [4] presents a composite model for a stimulating electrode that will estimate the spatio-temporal response of neural tissue in both a near-and far-field electrode geometry. In the second paper [5] , the authors confirm the validation of the model and demonstrate that the approach can be used to describe electrical stimulation for realistic physiological parameters.
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